Biologist, Postdoc researcher, Assay development for drug discovery projects, in vivo experiments, writing for funding support and patent fillings

BSRC AL. FLEMING,VARI, GR
Joined February 2020
Dimitra Papadopoulou retweeted
A wonderful collaboration with the medicinal chemistry lab of Alexios Matralis and valued colleagues! First small molecule leads targeting #fibroblast activation driving chronic #inflammatorydisease and #fibrosis.
1
6
1
20
1,395
An antipsychotic drug reduces arthritis in a fibroblast dependent model! Take a look on our work from @KolliasLab at @BSRC_Fleming published now in @JCI_insight. Thanks to our collaborators @Biomedcode @JesperOlsenLab
Repurposing the antipsychotic drug amisulpride for targeting synovial fibroblast activation in arthritis: buff.ly/42mYXhy @KolliasLab @BSRC_Fleming #Therapeutics
1
5
16
1,327
Happy that our work at @KolliasLab in @BSRC_Fleming is now available as a preprint! @biorxivpreprint #arthritis #fibroblasts #DrugRepurposing
Repurposing of Amisulpride, a known antipsychotic drug, to target synovial fibroblasts activation in arthritis. biorxiv.org/cgi/content/shor… #bioRxiv
5
1
23
The @KolliasLab @BSRC_Fleming is seeking motivated #postdocs to join a newly awarded #ERCAdG on “Contextual specification of #fibroblast driven causalities in #IBD and #fibrosis” @ERC_Research Info: bit.ly/3N8KIF3
9
12
Dimitra Papadopoulou retweeted
Kollias and colleagues examine FRC development during lymphoid organogenesis in gut PP: two separate mesenchymal cell lineages converge and form mosaic microenvironments that support immune cell activation and maintain intestinal homeostasis rdcu.be/cgNVz
1
22
3
50